Global $13.93 Bn Brain Tumor Drugs Markets, Analysis & Forecasts, 2015-2020, 2025F, 2030F
April 13, 2022 04:13 ET
|
Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Brain Tumor Drugs Global Market Opportunities And Strategies To 2030, By Drugs, End User" report has been added to ResearchAndMarkets.com's offering. ...
$3.4 Billion Worldwide Brain Tumor Drugs Industry to 2031 - Identify Growth Segments for Investment
April 12, 2022 05:53 ET
|
Research and Markets
Dublin, April 12, 2022 (GLOBE NEWSWIRE) -- The "Brain Tumor Drugs Global Market Report 2022, Type, Drugs, End User" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others
March 29, 2022 05:23 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2022, Tumor Type, Distribution Channel, Drug Type" report has been added to ResearchAndMarkets.com's...
The Worldwide Merkel Cell Carcinoma Disease Treatment Industry is Expected to Reach $3.7 Billion by 2026
March 01, 2022 07:08 ET
|
Research and Markets
Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "Merkel Cell Carcinoma Disease Treatment Market - Forecast 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The Merkel cell...
Global $2.89 Billion Brain Tumor Drugs Markets, 2015-2020, 2020-2025F, 2030F
June 24, 2021 04:03 ET
|
Research and Markets
Dublin, June 24, 2021 (GLOBE NEWSWIRE) -- The "Brain Tumor Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Global Cervical Cancer Market Report 2020: Insight, Epidemiology and Market Forecast 2017-2030 - Unmet Needs, Marketed Therapies, Emerging Therapies, Treatment and Management
December 08, 2020 03:18 ET
|
Research and Markets
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This...
Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference
November 15, 2018 08:30 ET
|
Otonomy, Inc.
SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David...
Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss
November 06, 2018 07:30 ET
|
Otonomy, Inc.
Society for Neuroscience Features OTO-413 Presentation as Neuroscience 2018 Hot Topic SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company...
Otonomy Announces OTIVIDEX™ Data Presentation at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual Meeting
October 02, 2018 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that...
Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication
August 06, 2018 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced the...